Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Cytokinetics reported $94K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Bayer BAYN:GR EUR 2.52B 0
Brainstorm Cell Therapeutics BCLI:US USD 12K 0
Capricor Therapeutics CAPR:US USD 25K 0
Cytokinetics CYTK:US USD 94K 0
Eisai 4523:JP JPY 44.99B 0
Eli Lilly LLY:US USD 593.5M 600K
Exelixis EXEL:US USD 325K 1000
Geron GERN:US USD 509K 119K
Halozyme Therapeutics HALO:US USD 132K 3K
Intra Cellular Therapies ITCI:US USD 10K 1000
Ionis Pharmaceuticals IONS:US USD 143K 1000
Novartis NOVN:VX USD 842M 48M
Roche Holding ROG:VX CHF 107M 0